JP2011522797A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011522797A5 JP2011522797A5 JP2011508908A JP2011508908A JP2011522797A5 JP 2011522797 A5 JP2011522797 A5 JP 2011522797A5 JP 2011508908 A JP2011508908 A JP 2011508908A JP 2011508908 A JP2011508908 A JP 2011508908A JP 2011522797 A5 JP2011522797 A5 JP 2011522797A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- phenyl
- pain
- hydrogen atom
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 38
- 125000000217 alkyl group Chemical group 0.000 claims description 28
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 25
- 125000004432 carbon atom Chemical group C* 0.000 claims description 22
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 20
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 20
- 125000003118 aryl group Chemical group 0.000 claims description 19
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 17
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 12
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 12
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 12
- 125000005842 heteroatom Chemical group 0.000 claims description 11
- 150000002430 hydrocarbons Chemical group 0.000 claims description 11
- 229910052717 sulfur Inorganic materials 0.000 claims description 11
- 125000004434 sulfur atom Chemical group 0.000 claims description 11
- 208000002193 Pain Diseases 0.000 claims description 10
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 9
- 229910052731 fluorine Inorganic materials 0.000 claims description 9
- 239000011737 fluorine Substances 0.000 claims description 9
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 8
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims description 8
- 208000004296 neuralgia Diseases 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 8
- -1 1- {1- [2- (benzyloxycarbonylmethyl-carbamoyl) -3-phenyl-propyl-disulfanylmethyl] -3-methylsulfanyl-propylcarbamoyloxy} -ethylisobutyric acid ester Chemical class 0.000 claims description 7
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 6
- 208000004454 Hyperalgesia Diseases 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 150000001204 N-oxides Chemical class 0.000 claims description 5
- 125000004423 acyloxy group Chemical group 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- RCCPEORTSYDPMB-UHFFFAOYSA-N hydroxy benzenecarboximidothioate Chemical compound OSC(=N)C1=CC=CC=C1 RCCPEORTSYDPMB-UHFFFAOYSA-N 0.000 claims description 5
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 5
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 4
- 206010065390 Inflammatory pain Diseases 0.000 claims description 4
- 208000001294 Nociceptive Pain Diseases 0.000 claims description 4
- 206010053552 allodynia Diseases 0.000 claims description 4
- 229930003827 cannabinoid Natural products 0.000 claims description 4
- 239000003557 cannabinoid Substances 0.000 claims description 4
- 229960002870 gabapentin Drugs 0.000 claims description 4
- 229960005181 morphine Drugs 0.000 claims description 4
- 208000021722 neuropathic pain Diseases 0.000 claims description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 4
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 claims description 4
- 229960001233 pregabalin Drugs 0.000 claims description 4
- 230000001107 psychogenic effect Effects 0.000 claims description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- 150000007529 inorganic bases Chemical class 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- TXIULPDGSSUSCN-UHFFFAOYSA-N 1-[[1-[[2-benzyl-3-[[2-(1-ethoxycarbonyloxyethoxy)-2-oxoethyl]amino]-3-oxopropyl]disulfanyl]-4-methylsulfanylbutan-2-yl]carbamoyloxy]ethyl 2-methylpropanoate Chemical compound CC(C)C(=O)OC(C)OC(=O)NC(CCSC)CSSCC(C(=O)NCC(=O)OC(C)OC(=O)OCC)CC1=CC=CC=C1 TXIULPDGSSUSCN-UHFFFAOYSA-N 0.000 claims description 2
- UVTAIEXQFOJKMH-UHFFFAOYSA-N 1-[[1-[[2-benzyl-3-[[2-(1-ethoxycarbonyloxyethoxy)-2-oxoethyl]amino]-3-oxopropyl]disulfanyl]-4-methylsulfinylbutan-2-yl]carbamoyloxy]ethyl 2-methylpropanoate Chemical compound CC(C)C(=O)OC(C)OC(=O)NC(CCS(C)=O)CSSCC(C(=O)NCC(=O)OC(C)OC(=O)OCC)CC1=CC=CC=C1 UVTAIEXQFOJKMH-UHFFFAOYSA-N 0.000 claims description 2
- JQCKBMKJYFQTDA-UHFFFAOYSA-N 2-[[1-[[[2-[1-(2-methylpropanoyloxy)ethoxycarbonylamino]-4-methylsulfinylbutyl]disulfanyl]methyl]cyclopentanecarbonyl]amino]butanedioic acid Chemical compound CC(C)C(=O)OC(C)OC(=O)NC(CCS(C)=O)CSSCC1(C(=O)NC(CC(O)=O)C(O)=O)CCCC1 JQCKBMKJYFQTDA-UHFFFAOYSA-N 0.000 claims description 2
- UDDHQXVDWLOJKB-UHFFFAOYSA-N 2-benzyl-2-[[1-[[[2-[1-(2-methylpropanoyloxy)ethoxycarbonylamino]-4-methylsulfanylbutyl]disulfanyl]methyl]cyclopentanecarbonyl]amino]butanedioic acid Chemical compound C=1C=CC=CC=1CC(CC(O)=O)(C(O)=O)NC(=O)C1(CSSCC(CCSC)NC(=O)OC(C)OC(=O)C(C)C)CCCC1 UDDHQXVDWLOJKB-UHFFFAOYSA-N 0.000 claims description 2
- FCYHPXFXUZFXBP-UHFFFAOYSA-N C(C1=CC=CC=C1)C(C(=O)O)(CC(=O)O)NC(=O)C1(CCCC1)CSSCC(CCS(=O)C)NC(=O)OC(C)OC(C(C)C)=O Chemical compound C(C1=CC=CC=C1)C(C(=O)O)(CC(=O)O)NC(=O)C1(CCCC1)CSSCC(CCS(=O)C)NC(=O)OC(C)OC(C(C)C)=O FCYHPXFXUZFXBP-UHFFFAOYSA-N 0.000 claims description 2
- JUSFYLHDQRWXQK-UHFFFAOYSA-N CCCCC[S+](NC(OC(C)OC(C(C)C)=O)=O)SC(C1(CCCC1)C(NC(CC([O-])=O)C(O)=O)=O)S Chemical compound CCCCC[S+](NC(OC(C)OC(C(C)C)=O)=O)SC(C1(CCCC1)C(NC(CC([O-])=O)C(O)=O)=O)S JUSFYLHDQRWXQK-UHFFFAOYSA-N 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 206010012335 Dependence Diseases 0.000 claims description 2
- 208000020401 Depressive disease Diseases 0.000 claims description 2
- 208000035154 Hyperesthesia Diseases 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 208000005298 acute pain Diseases 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- 229940065144 cannabinoids Drugs 0.000 claims description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical class C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims description 2
- 238000001990 intravenous administration Methods 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 201000006417 multiple sclerosis Diseases 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0853092A FR2931151A1 (fr) | 2008-05-13 | 2008-05-13 | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique |
| FR0853092 | 2008-05-13 | ||
| PCT/EP2009/055787 WO2009138436A1 (fr) | 2008-05-13 | 2009-05-13 | Nouveaux dérivés d'amino-acides, leur procédé de préparation et leur utilisation thérapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011522797A JP2011522797A (ja) | 2011-08-04 |
| JP2011522797A5 true JP2011522797A5 (https=) | 2012-06-28 |
| JP5642664B2 JP5642664B2 (ja) | 2014-12-17 |
Family
ID=40225670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011508908A Active JP5642664B2 (ja) | 2008-05-13 | 2009-05-13 | アミノ酸誘導体、その調製方法、およびその治療的使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8466309B2 (https=) |
| EP (1) | EP2297095B9 (https=) |
| JP (1) | JP5642664B2 (https=) |
| KR (1) | KR20110008325A (https=) |
| CN (2) | CN103739531B (https=) |
| AT (1) | ATE555084T1 (https=) |
| AU (1) | AU2009248056A1 (https=) |
| BR (1) | BRPI0912398A2 (https=) |
| CA (1) | CA2722840C (https=) |
| EA (1) | EA201071272A1 (https=) |
| FR (1) | FR2931151A1 (https=) |
| IL (1) | IL209214A (https=) |
| MX (1) | MX2010012273A (https=) |
| NZ (1) | NZ588955A (https=) |
| WO (1) | WO2009138436A1 (https=) |
| ZA (1) | ZA201008029B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2934267B1 (fr) * | 2008-07-23 | 2010-08-13 | Pharmaleads | Derives aminophosphiniques utiles dans le traitement de la douleur |
| FR2997080B1 (fr) * | 2012-10-23 | 2015-11-27 | Pharmaleads | Inhibiteurs de neprilysine |
| FR2997081B1 (fr) | 2012-10-23 | 2015-11-27 | Pharmaleads | Inhibiteurs mixtes de l'aminopeptidase n et de la neprilysine |
| TWI712582B (zh) * | 2015-10-14 | 2020-12-11 | 法商領先藥物公司 | 用來製備(5s,10s)-10-苄基-16-甲基-11,14,18-三側氧基-15,17,19-三氧雜-2,7,8-三噻基-12-氮二十一烷基-5-銨基(e)-3-羧基丙烯酸鹽的工業方法 |
| FR3077201B1 (fr) * | 2018-01-26 | 2020-01-17 | Pharmaleads | Derives aminoacides contenant un groupement disulfanyle sous forme d'un inhibiteur de nep et d'apn pour la prevention et le traitement des douleurs relatives au nerf trijumeau |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2480747A1 (fr) | 1980-04-17 | 1981-10-23 | Roques Bernard | Derives d'acides amines et leur application therapeutique |
| FR2488253A1 (fr) | 1980-08-08 | 1982-02-12 | Roques Bernard | Nouveaux peptides et leur application en therapeutique |
| FR2518088B1 (fr) | 1981-12-16 | 1987-11-27 | Roques Bernard | Nouveaux derives d'aminoacides, et leur application therapeutique |
| US4426391A (en) * | 1982-09-15 | 1984-01-17 | Merck & Co., Inc. | [(Alkoxycarbonyl)oxy]alkyl esters of methyldopa |
| EP0130119B1 (en) * | 1983-06-23 | 1988-11-09 | Merck & Co. Inc. | (acyloxyalkoxy) carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs, their preparation and pharmaceutical compositions containing said derivatives |
| US4916230A (en) * | 1984-07-02 | 1990-04-10 | Merck & Co., Inc. | Process for preparing novel N-(acyloxy-alkoxy)carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs |
| FR2605004B1 (fr) | 1986-09-25 | 1989-01-13 | Centre Nat Rech Scient | Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant |
| FR2611722B1 (fr) | 1987-03-02 | 1989-08-11 | Inst Nat Sante Rech Med | Nouveaux peptides derives de la cck8, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2634763B1 (fr) | 1988-08-01 | 1991-07-12 | Inst Nat Sante Rech Med | Amino-acides et peptides presentant un residu tyrosine modifiee, leur preparation et leur application comme medicaments |
| FR2651229B1 (fr) | 1989-08-24 | 1991-12-13 | Inst Nat Sante Rech Med | Nouveaux derives d'amino-acides, leur procede de preparation et leur application therapeutique. |
| FR2679564A1 (fr) | 1991-07-23 | 1993-01-29 | Inst Nat Sante Rech Med | Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent. |
| FR2729668A1 (fr) | 1995-01-23 | 1996-07-26 | Adir | Nouveaux derives de mercaptoalcanoyldipeptides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2745571B1 (fr) | 1996-03-04 | 1998-06-19 | Inst Nat Sante Rech Med | Nouveaux derives soufres comportant une liaison amide, leur procede de preparation, leur application a titre de medicaments, et les compositions pharmaceutiques les renfermant |
| FR2755135B1 (fr) | 1996-10-25 | 2002-12-27 | Inst Nat Sante Rech Med | Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent |
| FR2773712B1 (fr) | 1998-01-16 | 2000-06-02 | Inst Nat Sante Rech Med | Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a |
| FR2777780B1 (fr) | 1998-04-22 | 2001-05-04 | Inst Nat Sante Rech Med | Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent |
| US20020055463A1 (en) | 1998-12-24 | 2002-05-09 | Christiane Garbay | Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same |
| FR2788526B1 (fr) | 1999-01-20 | 2002-07-05 | Inst Nat Sante Rech Med | Composes tripeptidiques utiles a titre d'hinhibiteurs selectifs de l'aminopeptidase a et compositions pharmaceutiques correspondantes |
| FR2805259B1 (fr) | 2000-02-17 | 2002-03-29 | Inst Nat Sante Rech Med | Nouveaux derives d'aminoacides n-mercaptoacyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2807523B1 (fr) | 2000-04-07 | 2002-08-30 | Inst Nat Sante Rech Med | UTILISATION D'UN RESTE PyA-(Z)x-pNF A DES FINS DE DETECTION, IDENTIFICATION ET/OU DOSAGE PAR FLUORESCENCE |
| GB2362646A (en) * | 2000-05-26 | 2001-11-28 | Warner Lambert Co | Cyclic amino acid derivatives useful as pharmaceutical agents |
| FR2809733B1 (fr) | 2000-06-02 | 2004-04-30 | Inst Nat Sante Rech Med | Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants |
| ES2369256T3 (es) * | 2000-06-26 | 2011-11-28 | Helen Of Troy Limited | Sistema de lámpara recargable. |
| GB2365425A (en) * | 2000-08-01 | 2002-02-20 | Parke Davis & Co Ltd | Alkyl amino acid derivatives useful as pharmaceutical agents |
| DE60136747D1 (de) | 2000-09-11 | 2009-01-08 | Pasteur Institut | Mitochondrialen membrane permeabilisierung durch hiv-1 vpr und screeningsverfahren |
| FR2823212B1 (fr) | 2001-04-10 | 2005-12-02 | Inst Nat Sante Rech Med | Inhibiteurs de la toxine botulique de type b |
| ES2309336T3 (es) | 2002-07-16 | 2008-12-16 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Derivados de 4,4-ditiobis-(3-aminobutano-1-sulfanatos) nuevos y composiciones que los contienen. |
| FR2858617A1 (fr) | 2003-08-06 | 2005-02-11 | Inst Nat Sante Rech Med | Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant |
| ES2297742T3 (es) | 2004-05-05 | 2008-05-01 | Pharmaleads | Sustratos peptidicos reconocidos por la toxina botulinica de tipo a, bont/a y sus usos. |
| WO2007027477A2 (en) * | 2005-08-23 | 2007-03-08 | Xenoport, Inc. | Treating vulvodynia using prodrugs of gaba analogs |
| US8247609B2 (en) * | 2005-10-25 | 2012-08-21 | Pharamleads | Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors |
| WO2007048787A1 (fr) * | 2005-10-25 | 2007-05-03 | Pharmaleads | Derives d'amino-acides contenant un groupement disulfanyle comme inhibiteurs mixtes de la neprilysine et de l 'aminopeptidase n |
-
2008
- 2008-05-13 FR FR0853092A patent/FR2931151A1/fr not_active Withdrawn
-
2009
- 2009-05-13 KR KR1020107028001A patent/KR20110008325A/ko not_active Withdrawn
- 2009-05-13 WO PCT/EP2009/055787 patent/WO2009138436A1/fr not_active Ceased
- 2009-05-13 JP JP2011508908A patent/JP5642664B2/ja active Active
- 2009-05-13 EA EA201071272A patent/EA201071272A1/ru unknown
- 2009-05-13 CN CN201310736987.9A patent/CN103739531B/zh active Active
- 2009-05-13 BR BRPI0912398A patent/BRPI0912398A2/pt not_active IP Right Cessation
- 2009-05-13 MX MX2010012273A patent/MX2010012273A/es not_active Application Discontinuation
- 2009-05-13 AT AT09745768T patent/ATE555084T1/de active
- 2009-05-13 EP EP09745768A patent/EP2297095B9/fr active Active
- 2009-05-13 CN CN200980116831.2A patent/CN102026966B/zh active Active
- 2009-05-13 NZ NZ588955A patent/NZ588955A/en not_active IP Right Cessation
- 2009-05-13 AU AU2009248056A patent/AU2009248056A1/en not_active Abandoned
- 2009-05-13 CA CA2722840A patent/CA2722840C/fr active Active
- 2009-05-13 US US12/991,999 patent/US8466309B2/en active Active
-
2010
- 2010-11-09 ZA ZA2010/08029A patent/ZA201008029B/en unknown
- 2010-11-09 IL IL209214A patent/IL209214A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA023500B1 (ru) | Соединения, композиции и способы их применения для коррекции уровня мочевой кислоты | |
| KR102610573B1 (ko) | 통풍 또는 고뇨산혈증과 관련된 증상의 치료 또는 예방을 위한 화합물, 조성물 및 방법 | |
| JP2011522797A5 (https=) | ||
| AR061663A1 (es) | Procesos para la preparacion de inhibidores de iv dpp. composiciones farmaceuticas y compuestos relacionados. | |
| ES2781681T3 (es) | Profármacos de ésteres de [3-(1-(1H-imidazol-4-il)etil)-2-metilfenil]-metanol para reducir la presión intraocular | |
| EA201170522A1 (ru) | Новые гетероциклические азотсодержащие соединения, их получение и их применение в качестве антибактериальных лекарственных средств | |
| RU2001131111A (ru) | Новые соединения, их получение и применение | |
| RU2012125372A (ru) | Производные пиразола в качестве ингибиторов 11-бета-hsd1 | |
| EP2423207A3 (en) | 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors | |
| CA2565813A1 (en) | Substituted methyl aryl or heteroaryl amide compounds | |
| WO2008115098A3 (fr) | 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation | |
| JP2010539179A5 (https=) | ||
| KR900015729A (ko) | 흥분성 아미노산 길항제 | |
| CN1268134A (zh) | 具有抗转移活性的双吲哚衍生物、其制备方法和含有它们的药物组合物 | |
| JP2016529235A5 (https=) | ||
| WO2008157404A3 (en) | Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators | |
| JP2018529648A5 (https=) | ||
| MX2025010256A (es) | Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno | |
| EA200870224A1 (ru) | Бензо[f]изоиндол-2-илфенильные производные уксусной кислоты в качестве агонистов рецепторов ep | |
| RU2011100106A (ru) | Замещенные бензимидазолы для лечения нейрофиброматоза | |
| WO2010082212A3 (en) | N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses | |
| EA200900481A1 (ru) | Новые соединения индола, способ их получения и фармацевтические композиции, которые их содержат | |
| PE20030929A1 (es) | Acidos 3-(imidazolil)-2-alcoxipropanoicos | |
| JOP20240119A1 (ar) | مشتقات نافثيريدينون لمعالجة مرض أو اضطراب | |
| HRP20110858T1 (hr) | Kombinacija bistiazolijeve soli, ili njene preteče, s artemizininom ili njegovim derivatom, namijenjena liječenju teške malarije |